National Oxygen Limited Files SEBI Compliance Certificate for Quarter Ended March 31, 2026

1 min read     Updated on 13 Apr 2026, 05:37 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

National Oxygen Limited filed its confirmation certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, through registrar Cameo Corporate Services Limited. The certificate confirms proper handling of securities dematerialisation and compliance with depositories regulations. Managing Director Rajesh Kumar Saraf submitted the filing to Bombay Stock Exchange on April 13, 2026.

powered bylight_fuzz_icon
37627646

*this image is generated using AI for illustrative purposes only.

National Oxygen Limited has filed its quarterly compliance certificate with the Bombay Stock Exchange, confirming adherence to SEBI regulations for the quarter ended March 31, 2026. The submission demonstrates the company's commitment to regulatory compliance in securities handling and dematerialisation processes.

Regulatory Compliance Filing

The company submitted the confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 13, 2026. Managing Director Rajesh Kumar Saraf signed the filing, which was addressed to the Department of Corporate Services at the Bombay Stock Exchange.

Filing Details: Information
Regulation: SEBI Regulation 74(5)
Quarter Ended: March 31, 2026
Filing Date: April 13, 2026
Signatory: Rajesh Kumar Saraf, Managing Director
DIN: 00007353

Certificate Confirmation

Cameo Corporate Services Limited, serving as the company's registrar and share transfer agent, issued the compliance certificate. The certificate confirms that securities received from depository participants for dematerialisation during the quarter were properly processed and confirmed to the depositories within stipulated timeframes.

Key Compliance Confirmations

The certificate validates several critical compliance aspects:

  • Securities received for dematerialisation were confirmed (accepted/rejected) to depositories
  • Securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
  • Security certificates received for dematerialisation were mutilated and cancelled after due verification
  • Depository names were substituted in the register of members as registered owners within stipulated time limits

Company Operations

National Oxygen Limited operates as an ISO 9001:2015 certified manufacturer of industrial and medical gases. The company produces liquid and gaseous oxygen, nitrogen, nitrous oxide, medical oxygen, and dissolved acetylene gas through its three manufacturing facilities located in Puducherry, Erode, and Pudukkottai districts.

The quarterly filing reflects the company's ongoing commitment to maintaining regulatory compliance while continuing its operations in the industrial gases sector. The proper handling of securities dematerialisation ensures investor confidence and adherence to market regulations.

Historical Stock Returns for National Oxygen

1 Day5 Days1 Month6 Months1 Year5 Years
-2.30%+4.62%+11.38%-37.61%-34.90%+23.30%

How might National Oxygen's expansion plans be affected by recent regulatory changes in the industrial gases sector?

What impact could rising demand for medical oxygen post-pandemic have on the company's production capacity and revenue growth?

Will National Oxygen consider establishing additional manufacturing facilities beyond its current three locations to capture market opportunities?

National Oxygen Board Approves 9.50 Lakh Equity Shares Preferential Issue

1 min read     Updated on 20 Mar 2026, 06:59 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

National Oxygen Limited's board meeting on March 20, 2026, approved the preferential issue of up to 9.50 lakh equity shares with face value of Rs. 10.00 each to promoter group company Saraf Housing Development Private Limited. The company appointed CA S Dehaleesan as registered valuer and approved opening a separate bank account for the issue process, ensuring compliance with SEBI ICDR Regulations 2018.

powered bylight_fuzz_icon
35298127

*this image is generated using AI for illustrative purposes only.

National oxygen Limited's board of directors has approved the preferential allotment of up to 9.50 lakh equity shares to promoter group company Saraf Housing Development Private Limited. The board meeting, held on March 20, 2026, concluded the fundraising proposal that was initially scheduled for consideration.

Board Meeting Outcome

The board meeting, which commenced at 4:00 PM and concluded at 4:30 PM on March 20, 2026, resulted in the approval of several key resolutions related to the equity fundraising initiative.

Parameter: Details
Approved Share Issue: Up to 9.50 lakh equity shares
Face Value: Rs. 10.00 per share
Allottee: Saraf Housing Development Private Limited
Issue Method: Preferential allotment
Regulatory Compliance: SEBI ICDR Regulations, 2018

Key Appointments and Approvals

The board appointed CA S Dehaleesan as the registered valuer for determining the issue price of the preferential allotment. CA Dehaleesan holds the registered valuer number IBBI/RV/04/2019/11659 and will be responsible for price determination in accordance with SEBI regulations.

Additionally, the board approved the opening of a separate bank account specifically for the preferential issue process, ensuring proper segregation of funds and compliance with regulatory requirements.

Regulatory Framework and Compliance

The approved equity issue will be conducted under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013. The issue price will be determined at not less than the price calculated in accordance with SEBI ICDR Regulations.

Saraf Housing Development Private Limited, being part of the promoter group, will be the sole recipient of the preferential allotment. The company has made the necessary disclosures under Regulation 30 of SEBI Listing Regulations and SEBI Circular dated July 13, 2023.

Company Operations

National Oxygen Limited operates as an ISO 9001:2015 certified manufacturer specializing in industrial and medical gases. The Chennai-based company manufactures liquid and gaseous oxygen, nitrogen, nitrous oxide, medical oxygen, and dissolved acetylene gas. With manufacturing facilities across Tamil Nadu and Puducherry, the company serves various industrial sectors under its tagline "Breathing Life Into Industry."

Historical Stock Returns for National Oxygen

1 Day5 Days1 Month6 Months1 Year5 Years
-2.30%+4.62%+11.38%-37.61%-34.90%+23.30%

How will National Oxygen Limited utilize the funds raised from this Rs. 9.5 crore preferential allotment for expanding its industrial and medical gas operations?

What impact could this promoter group funding have on National Oxygen's competitive position in the Tamil Nadu and Puducherry industrial gas markets?

Will the company consider additional fundraising rounds or explore public offerings to support further expansion beyond South India?

More News on National Oxygen

1 Year Returns:-34.90%